M. Beaulieu

Emerging health technology firms’ strategies and their impact on economic and healthcare system actors: a qualitative study

P. Lehoux, P. Lehoux, M. Beaulieu, 2018, Journal of Innovation and Entrepreneurship.

The emergence of health technology organizations among institutional healthcare and economic actors

P. Lehoux, M. Beaulieu, 2018, International Entrepreneurship and Management Journal.

Do proton-pump inhibitors increase the risk for nosocomial pneumonia in a medical intensive care unit?

M. Beaulieu, D. Williamson, J. Lachaine, 2008, Journal of critical care.

Clostridium difficile-associated diarrhea outbreaks: the name of the game is isolation and cleaning.

M. Beaulieu, D. Williamson, D. Thirion, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Chronic intermittent elemental diet improves growth failure in children with Crohn's disease.

E. Seidman, M. Beaulieu, D. Belli, 1988, Gastroenterology.

Systematic review of pharmacoeconomic studies of pharmacogenomic tests.

Mathieu Beaulieu, S. de Denus, M. Beaulieu, 2010, Pharmacogenomics.

Risk of Clostridium difficile-Associated Disease Among Patients Receiving Proton-Pump Inhibitors in a Quebec Medical Intensive Care Unit

M. Beaulieu, D. Williamson, J. Lachaine, 2007, Infection Control & Hospital Epidemiology.

Emerging health technology firms’ strategies and their impact on economic and healthcare system actors: a qualitative study

P. Lehoux, M. Beaulieu, 2018, Journal of Innovation and Entrepreneurship.